人工肺の世界市場レポート 2025年

人工肺市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR11.9％で40億6,000万米ドルに成長します。予測期間の成長は、呼吸器疾患の有病率上昇、ヘルスケア施設の改善、低侵襲処置の受け入れ拡大、患者のQOL向上、慢性閉塞性肺疾患の有病率上昇に起因します。予測期間における主な動向としては、ワイヤレス技術の統合、人工知能（AI）の統合、ゲノミクスと医療技術の進歩、より小型で持ち運び可能な人工肺の開発などが挙げられます。

人工肺市場は、呼吸器疾患の有病率の増加によって成長が見込まれます。この増加は、大気汚染の深刻化、気候変動、ライフスタイルの変化などの要因に影響され、公衆衛生に大きな負担を強いています。人工肺は、酸素供給を行い、血液から二酸化炭素を除去し、損なわれた肺機能をサポートまたは代替することにより、呼吸器疾患の治療において重要な役割を果たしています。例えば、オーストラリア保健福祉研究所が2024年6月に報告したように、オーストラリアでは人口の34％を占める約850万人が慢性呼吸器疾患を患っていると推定されています。その内訳は、喘息が280万人（人口の11％）、慢性閉塞性肺疾患（COPD）が63万8,000人（人口の2.5％）です。このように、呼吸器疾患の有病率の増加は、人工肺市場拡大の重要な促進要因となっています。

人工肺市場の主要企業は、競争優位性を獲得するため、遠隔監視・制御システムなどの革新的ソリューションの開拓に注力しています。これらのシステムは、ヘルスケア専門家がベッドサイドにいなくても、患者のバイタルサインをモニタリングしたり、換気設定を遠隔で調整したりすることを可能にします。このアプローチは感染リスクの低減に役立ち、治療中の患者の安全性を向上させる。例えば、2022年8月、米国の電子機器メーカーであるTeltonika Telemedic社は、同社の人工肺人工呼吸器「TELTOMED」の開発で大きく前進しました。同社は、人工呼吸器の安全な遠隔トランスミッションと制御に関する独占特許を取得し、最新の医療機器に不可欠な患者データ通信のセキュリティと信頼性を強化しました。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界人工肺 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の人工肺市場：成長率分析
• 世界の人工肺市場の実績：規模と成長, 2019-2024
• 世界の人工肺市場の予測：規模と成長, 2024-2029, 2034F
• 世界人工肺総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の人工肺市場：製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• シングルローラーポンプ式人工心肺装置
• ダブルローラーポンプ式人工心肺装置
• バブル人工肺
• 膜人工肺
• 世界の人工肺市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 心臓手術
• 肺移植手術
• 急性呼吸不全の治療
• その他の用途
• 世界の人工肺市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 救急センター
• その他のエンドユーザー
• 世界の人工肺市場シングルローラーポンプ式人工心肺装置のサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• ポータブルシングルローラーポンプ式人工心肺装置
• 据置型式シングルローラーポンプ式人工心肺装置
• 世界の人工肺市場ダブルローラーポンプ人工心肺装置のサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• ポータブルダブルローラーポンプ人工心肺装置
• 据置型ダブルローラーポンプ式人工心肺装置
• 世界の人工肺市場バブル人工肺のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 使い捨てバブル人工肺
• 再利用可能なバブル人工肺
• 世界の人工肺市場膜型人工肺のサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 酸素化膜人工肺
• 二酸化炭素除去膜人工肺

第7章 地域別・国別分析

• 世界の人工肺市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の人工肺市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 人工肺市場：競合情勢
• 人工肺市場：企業プロファイル
  • Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Getinge AB Overview, Products and Services, Strategy and Financial Analysis
  • Abiomed Inc. Overview, Products and Services, Strategy and Financial Analysis
  • MicroPort Scientific Corp. Overview, Products and Services, Strategy and Financial Analysis
  • Charles Stark Draper Laboratory Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• TransMedics Group Inc.
• Braile Biomedica Ltd.
• Xenios AG
• MC3 Cardiopulmonary Inc.
• Lung Biotechnology PBC
• Breethe Inc.
• Levitronix LLC
• Medos Medizintechnik AG
• ALung Technologies Inc.
• McGowan Institute for Regenerative Medicine
• Hemovent GmbH
• Novalung GmbH
• Haemair Ltd.
• MedArray Inc.
• Vivonics Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 人工肺市場2029：新たな機会を提供する国
• 人工肺市場2029：新たな機会を提供するセグメント
• 人工肺市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

An artificial lung is a medical device created to assume the function of natural lungs by supplying oxygen to the blood and eliminating carbon dioxide. It is commonly employed in patients experiencing severe respiratory failure or during surgeries where temporary cessation of heart and lung function is necessary. This technology aims to support or replace lung function, facilitating patient survival and recovery from critical conditions.

The primary types of artificial lungs include single roller pump heart-lung machines, double roller pump heart-lung machines, bubble artificial lungs, and membrane artificial lungs. A single roller pump heart-lung machine operates using a single roller pump to circulate blood through an artificial lung and back into the patient during cardiopulmonary bypass surgery. These machines are utilized in cardiac surgery, lung transplants, acute respiratory failure treatments, and other medical procedures, catering to diverse end users such as hospitals, emergency centers, and healthcare facilities.

The artificial lung research report is one of a series of new reports from The Business Research Company that provides artificial lung market statistics, including the artificial lung industry's global market size, regional shares, competitors with an artificial lung market share, detailed artificial lung market segments, market trends and opportunities, and any further data you may need to thrive in the artificial lung industry. This artificial lung market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The artificial lung market size has grown rapidly in recent years. It will grow from $2.31 billion in 2024 to $2.59 billion in 2025 at a compound annual growth rate (CAGR) of 12.2%. The growth in the historic period can be attributed to growing awareness among healthcare professionals, increasing market penetration, increasing applications in-home care setting, the rise in medical tourism, and improvements in healthcare infrastructure.

The artificial lung market size is expected to see rapid growth in the next few years. It will grow to $4.06 billion in 2029 at a compound annual growth rate (CAGR) of 11.9%. The growth in the forecast period can be attributed to the rising prevalence of respiratory diseases, improvements in healthcare facilities, rising acceptance of minimally invasive procedures, enhanced patient quality of life, and rising prevalence of chronic obstructive pulmonary diseases. Major trends in the forecast period include the integration of wireless technology, artificial intelligence (AI) integration, advances in genomics and medical technology, and the development of smaller, more portable artificial lungs.

The artificial lung market is expected to experience growth driven by the increasing prevalence of respiratory diseases. This rise is influenced by factors such as escalating air pollution, climate changes, and shifts in lifestyle, placing a substantial burden on public health. Artificial lungs play a critical role in treating respiratory conditions by providing oxygenation and removing carbon dioxide from the blood, supporting or replacing impaired lung function. For example, as reported by the Australian Institute of Health and Welfare in June 2024, approximately 8.5 million people in Australia, constituting 34% of the population, were estimated to have chronic respiratory conditions. This includes 2.8 million people (11% of the population) with asthma and 638,000 people (2.5% of the population) with chronic obstructive pulmonary disease (COPD). Thus, the growing prevalence of respiratory diseases is a key driver behind the expansion of the artificial lung market.

Major companies in the artificial lung market are focusing on developing innovative solutions, such as remote monitoring and control systems, to gain a competitive edge. These systems enable healthcare professionals to monitor patients' vital signs and adjust ventilation settings remotely, without needing to be physically present at the bedside. This approach helps reduce the risk of infection and improves patient safety during treatment. For example, in August 2022, Teltonika Telemedic, a U.S.-based electronics manufacturer, made significant strides in developing its artificial lung ventilator, TELTOMED. The company secured an exclusive patent for the secure remote transmission and control of its ventilator, enhancing the security and reliability of patient data communication-an essential feature for modern medical devices.

In May 2022, LivaNova plc, a UK-based medical device company, acquired ALung Technologies to bolster its portfolio in advanced respiratory therapies. This acquisition aimed to strengthen LivaNova's capability to deliver innovative solutions for respiratory support, particularly focusing on advancing artificial lung technologies. ALung Technologies, headquartered in the US, specializes in developing intra- and extracorporeal gas exchange devices for treating acute and chronic respiratory disorders.

Major companies operating in the artificial lung market are Terumo Corporation, Getinge AB, Abiomed Inc., MicroPort Scientific Corp., Charles Stark Draper Laboratory Inc., TransMedics Group Inc., Braile Biomedica Ltd., Xenios AG, MC3 Cardiopulmonary Inc., Lung Biotechnology PBC, Breethe Inc., Levitronix LLC, Medos Medizintechnik AG, ALung Technologies Inc., McGowan Institute for Regenerative Medicine, Hemovent GmbH, Novalung GmbH, Haemair Ltd., MedArray Inc., Vivonics Inc., Extracorporeal Life Support (ECLS) Lab

North America was the largest region in the artificial lung market in 2024. The regions covered in the artificial lung market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the artificial lung market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial lung market consists of sales of extracorporeal membrane oxygenation (ECMO), intravenous membrane oxygenators (IVOX), bioartificial lungs, and microfluidic artificial lungs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Lung Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial lung market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial lung ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The artificial lung market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Single Roller Pump Heart Lung Machines; Double Roller Pump Heart Lungs Machines; Bubble Artificial Lung; Membrane Artificial Lung
• 2) By Application: Cardiac Surgery; Lung Transplant Operation; Acute Respiratory Failure Treatment; Other Applications
• 3) By End-Users: Hospital; Emergency Center; Other End-users
• Subsegments:
• 1) By Single Roller Pump Heart Lung Machines: Portable Single Roller Pump Heart Lung Machines; Stationary Single Roller Pump Heart Lung Machines
• 2) By Double Roller Pump Heart Lung Machines: Portable Double Roller Pump Heart Lung Machines; Stationary Double Roller Pump Heart Lung Machines
• 3) By Bubble Artificial Lung: Disposable Bubble Artificial Lung; Reusable Bubble Artificial Lung
• 4) By Membrane Artificial Lung: Oxygenator Membrane Artificial Lung; Carbon Dioxide Removal Membrane Artificial Lung
• Companies Mentioned: Terumo Corporation; Getinge AB; Abiomed Inc.; MicroPort Scientific Corp.; Charles Stark Draper Laboratory Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Artificial Lung Market Characteristics

3. Artificial Lung Market Trends And Strategies

4. Artificial Lung Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Artificial Lung Growth Analysis And Strategic Analysis Framework

• 5.1. Global Artificial Lung PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Artificial Lung Market Growth Rate Analysis
• 5.4. Global Artificial Lung Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Artificial Lung Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Artificial Lung Total Addressable Market (TAM)

6. Artificial Lung Market Segmentation

• 6.1. Global Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single Roller Pump Heart Lung Machines
• Double Roller Pump Heart Lungs Machines
• Bubble Artificial Lung
• Membrane Artificial Lung
• 6.2. Global Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cardiac Surgery
• Lung Transplant Operation
• Acute Respiratory Failure Treatment
• Other Applications
• 6.3. Global Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital
• Emergency Center
• Other End-user
• 6.4. Global Artificial Lung Market, Sub-Segmentation Of Single Roller Pump Heart Lung Machines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Portable Single Roller Pump Heart Lung Machines
• Stationary Single Roller Pump Heart Lung Machines
• 6.5. Global Artificial Lung Market, Sub-Segmentation Of Double Roller Pump Heart Lung Machines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Portable Double Roller Pump Heart Lung Machines
• Stationary Double Roller Pump Heart Lung Machines
• 6.6. Global Artificial Lung Market, Sub-Segmentation Of Bubble Artificial Lung, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Disposable Bubble Artificial Lung
• Reusable Bubble Artificial Lung
• 6.7. Global Artificial Lung Market, Sub-Segmentation Of Membrane Artificial Lung, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oxygenator Membrane Artificial Lung
• Carbon Dioxide Removal Membrane Artificial Lung

7. Artificial Lung Market Regional And Country Analysis

• 7.1. Global Artificial Lung Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Artificial Lung Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Artificial Lung Market

• 8.1. Asia-Pacific Artificial Lung Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Artificial Lung Market

• 9.1. China Artificial Lung Market Overview
• 9.2. China Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Artificial Lung Market

• 10.1. India Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Artificial Lung Market

• 11.1. Japan Artificial Lung Market Overview
• 11.2. Japan Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Artificial Lung Market

• 12.1. Australia Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Artificial Lung Market

• 13.1. Indonesia Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Artificial Lung Market

• 14.1. South Korea Artificial Lung Market Overview
• 14.2. South Korea Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Artificial Lung Market

• 15.1. Western Europe Artificial Lung Market Overview
• 15.2. Western Europe Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Artificial Lung Market

• 16.1. UK Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Artificial Lung Market

• 17.1. Germany Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Artificial Lung Market

• 18.1. France Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Artificial Lung Market

• 19.1. Italy Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Artificial Lung Market

• 20.1. Spain Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Artificial Lung Market

• 21.1. Eastern Europe Artificial Lung Market Overview
• 21.2. Eastern Europe Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Artificial Lung Market

• 22.1. Russia Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Artificial Lung Market

• 23.1. North America Artificial Lung Market Overview
• 23.2. North America Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Artificial Lung Market

• 24.1. USA Artificial Lung Market Overview
• 24.2. USA Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Artificial Lung Market

• 25.1. Canada Artificial Lung Market Overview
• 25.2. Canada Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Artificial Lung Market

• 26.1. South America Artificial Lung Market Overview
• 26.2. South America Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Artificial Lung Market

• 27.1. Brazil Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Artificial Lung Market

• 28.1. Middle East Artificial Lung Market Overview
• 28.2. Middle East Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Artificial Lung Market

• 29.1. Africa Artificial Lung Market Overview
• 29.2. Africa Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Artificial Lung Market Competitive Landscape And Company Profiles

• 30.1. Artificial Lung Market Competitive Landscape
• 30.2. Artificial Lung Market Company Profiles
  • 30.2.1. Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Getinge AB Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abiomed Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. MicroPort Scientific Corp. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Charles Stark Draper Laboratory Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Artificial Lung Market Other Major And Innovative Companies

• 31.1. TransMedics Group Inc.
• 31.2. Braile Biomedica Ltd.
• 31.3. Xenios AG
• 31.4. MC3 Cardiopulmonary Inc.
• 31.5. Lung Biotechnology PBC
• 31.6. Breethe Inc.
• 31.7. Levitronix LLC
• 31.8. Medos Medizintechnik AG
• 31.9. ALung Technologies Inc.
• 31.10. McGowan Institute for Regenerative Medicine
• 31.11. Hemovent GmbH
• 31.12. Novalung GmbH
• 31.13. Haemair Ltd.
• 31.14. MedArray Inc.
• 31.15. Vivonics Inc.

32. Global Artificial Lung Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Artificial Lung Market

34. Recent Developments In The Artificial Lung Market

35. Artificial Lung Market High Potential Countries, Segments and Strategies

• 35.1 Artificial Lung Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Artificial Lung Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Artificial Lung Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer